{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:50:38Z","timestamp":1784955038564,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/30\/E\/NZ5\/00065"],"award-info":[{"award-number":["2018\/30\/E\/NZ5\/00065"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2021\/43\/B\/NZ5\/00723"],"award-info":[{"award-number":["2021\/43\/B\/NZ5\/00723"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Duchenne muscular dystrophy (DMD) is an X-linked disease caused by mutations in the dystrophin gene. DMD manifests with progressive skeletal muscle wasting, cardiac dysfunction, and cognitive and neuropsychiatric symptoms. As the disease progresses, affected boys lose their ability to walk and die prematurely. All DMD patients lack the full-length DP427 dystrophin, whereas approximately 10% lose all dystrophins, including DP71, synthesized in various cell types, including myoblasts. There is evidence that the cognitive symptoms of DMD patients vary depending on the location of the mutation site and the number of missing dystrophins, and there is some indication that this may also be the case in skeletal muscle. We therefore investigated the roles of DP427 and DP71 during cell proliferation and fibre differentiation. We included paralogous utrophins in our analyses, particularly the UP395 isoform, owing to its presence in muscle and its partial ability to compensate for the lack of DP427. We demonstrated that DP71 and DP427 play important roles in cell viability during cell proliferation and fibre differentiation, respectively. Despite their different expression patterns, the absence of DP71 and DP427 resulted in a similar phenotype, including increased membrane permeability, mitochondrial aggregation, elevated ROS, and increased cyto- and genotoxicity, but induced substantially different transcriptome programs associated with impaired cell proliferation and structural reorganization of myotubes, respectively. The phenotype occurred independently of myofibre contraction, dysfunction of neuromuscular or myotendinous junctions, or other cell types. We further showed that the utrophin UP395 can partially compensate not only for DP427 but also for DP71. These results explain the observed differences in disease severity among DMD patients and suggest that individuals deficient in both DP71 and DP427 may require a different therapeutic approach than patients deficient in only DP427.<\/jats:p>","DOI":"10.1038\/s41419-026-08725-x","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:37:09Z","timestamp":1775885829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dystrophins DP71 and DP427 determine cell viability during proliferation and myofibre differentiation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6986-833X","authenticated-orcid":false,"given":"Sylwia","family":"Szwec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-5596","authenticated-orcid":false,"given":"Alicja","family":"Durska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-6624","authenticated-orcid":false,"given":"Paulina","family":"Ko\u015bcielniak-Wawro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-0059","authenticated-orcid":false,"given":"Jeffrey S.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1690-1228","authenticated-orcid":false,"given":"Oleksandr","family":"Ostrovskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-5196","authenticated-orcid":false,"given":"Karolina","family":"Dominiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7223-228X","authenticated-orcid":false,"given":"Solmaz","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-8254","authenticated-orcid":false,"given":"Patryk","family":"Konieczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"8725_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"S Crisafulli","year":"2020","unstructured":"Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifiro G. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis. 2020;15:141.","journal-title":"Orphanet J Rare Dis"},{"key":"8725_CR2","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/cpt.3363","volume":"116","author":"P Konieczny","year":"2024","unstructured":"Konieczny P. Systemic treatment of body-wide Duchenne muscular dystrophy symptoms. Clin Pharmacol Ther. 2024;116:1472\u201384.","journal-title":"Clin Pharmacol Ther"},{"key":"8725_CR3","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1111\/febs.15466","volume":"287","author":"EP Hoffman","year":"2020","unstructured":"Hoffman EP. The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene. FEBS J. 2020;287:3879\u201387.","journal-title":"FEBS J"},{"key":"8725_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.117.001782","volume":"11","author":"T Yamamoto","year":"2018","unstructured":"Yamamoto T, Awano H, Zhang Z, Sakuma M, Kitaaki S, Matsumoto M, et al. Cardiac dysfunction in Duchenne muscular dystrophy is less frequent in patients with mutations in the dystrophin Dp116 coding region than in other regions. Circ Genom Precis Med. 2018;11:e001782.","journal-title":"Circ Genom Precis Med"},{"key":"8725_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12981-5","volume":"7","author":"N Doorenweerd","year":"2017","unstructured":"Doorenweerd N, Mahfouz A, van Putten M, Kaliyaperumal R, t\u2019Hoen PAC, Hendriksen JGM, et al. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy. Sci Rep. 2017;7:12575.","journal-title":"Sci Rep"},{"key":"8725_CR6","doi-asserted-by":"crossref","unstructured":"Alnassar N, Hajto J, Rumney RMH, Verma S, Borczyk M, Saha C, et al. Ablation of the dystrophin Dp71f alternative C-terminal variant increases sarcoma tumour cell aggressiveness. Hum Mol Genet. 2024;ddae094.","DOI":"10.1093\/hmg\/ddae094"},{"key":"8725_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74157-y","volume":"10","author":"M Farea","year":"2020","unstructured":"Farea M, Rani AQM, Maeta K, Nishio H, Matsuo M. Dystrophin Dp71ab is monoclonally expressed in human satellite cells and enhances proliferation of myoblast cells. Sci Rep. 2020;10:17123.","journal-title":"Sci Rep"},{"key":"8725_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40259-023-00632-3","volume":"38","author":"S Szwec","year":"2024","unstructured":"Szwec S, Kaplucha Z, Chamberlain JS, Konieczny P. Dystrophin- and utrophin-based therapeutic approaches for treatment of duchenne muscular dystrophy: a comparative review. BioDrugs. 2024;38:95\u2013119.","journal-title":"BioDrugs"},{"key":"8725_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng1294-333","volume":"8","author":"GA Cox","year":"1994","unstructured":"Cox GA, Sunada Y, Campbell KP, Chamberlain JS. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet. 1994;8:333\u20139.","journal-title":"Nat Genet"},{"key":"8725_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/ng1294-340","volume":"8","author":"DS Greenberg","year":"1994","unstructured":"Greenberg DS, Sunada Y, Campbell KP, Yaffe D, Nudel U. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat Genet. 1994;8:340\u20134.","journal-title":"Nat Genet"},{"key":"8725_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/hmg\/11.9.1095","volume":"11","author":"LE Warner","year":"2002","unstructured":"Warner LE, DelloRusso C, Crawford RW, Rybakova IN, Patel JR, Ervasti JM, et al. Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Hum Mol Genet. 2002;11:1095\u2013105.","journal-title":"Hum Mol Genet"},{"key":"8725_CR12","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/hmg\/ddz049","volume":"28","author":"S Guiraud","year":"2019","unstructured":"Guiraud S, Edwards B, Babbs A, Squire SE, Berg A, Moir L, et al. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. Hum Mol Genet. 2019;28:2189\u2013200.","journal-title":"Hum Mol Genet"},{"key":"8725_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-04892-x","volume":"12","author":"AV Starikova","year":"2022","unstructured":"Starikova AV, Skopenkova VV, Polikarpova AV, Reshetov DA, Vassilieva SG, Velyaev OA, et al. Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression. Sci Rep. 2022;12:848.","journal-title":"Sci Rep"},{"key":"8725_CR14","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41591-019-0594-0","volume":"25","author":"Y Song","year":"2019","unstructured":"Song Y, Morales L, Malik AS, Mead AF, Greer CD, Mitchell MA, et al. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models. Nat Med. 2019;25:1505\u201311.","journal-title":"Nat Med"},{"key":"8725_CR15","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1074\/jbc.M411571200","volume":"280","author":"MB de Leon","year":"2005","unstructured":"de Leon MB, Montanez C, Gomez P, Morales-Lazaro SL, Tapia-Ramirez V, Valadez-Graham V, et al. Dystrophin Dp71 expression is down-regulated during myogenesis: role of Sp1 and Sp3 on the Dp71 promoter activity. J Biol Chem. 2005;280:5290\u201399.","journal-title":"J Biol Chem"},{"key":"8725_CR16","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/1873-3468.13099","volume":"592","author":"KJ Perkins","year":"2018","unstructured":"Perkins KJ, Davies KE. Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy. FEBS Lett. 2018;592:1856\u201369.","journal-title":"FEBS Lett"},{"key":"8725_CR17","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1083\/jcb.200604179","volume":"176","author":"GA Rezniczek","year":"2007","unstructured":"Rezniczek GA, Konieczny P, Nikolic B, Reipert S, Schneller D, Abrahamsberg C, et al. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibres through multiple interactions with beta-dystroglycan. J Cell Biol. 2007;176:965\u201377.","journal-title":"J Cell Biol"},{"key":"8725_CR18","doi-asserted-by":"publisher","first-page":"e0150818","DOI":"10.1371\/journal.pone.0150818","volume":"11","author":"N Janghra","year":"2016","unstructured":"Janghra N, Morgan JE, Sewry CA, Wilson FX, Davies KE, Muntoni F, et al. Correlation of utrophin levels with the dystrophin protein complex and muscle fibre regeneration in duchenne and becker muscular dystrophy muscle biopsies. PLoS ONE. 2016;11:e0150818.","journal-title":"PLoS ONE"},{"key":"8725_CR19","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1242\/jcs.064808","volume":"123","author":"D Li","year":"2010","unstructured":"Li D, Bareja A, Judge L, Yue Y, Lai Y, Fairclough R, et al. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci. 2010;123:2008\u201313.","journal-title":"J Cell Sci"},{"key":"8725_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","volume":"27","author":"JN Ramos","year":"2019","unstructured":"Ramos JN, Hollinger K, Bengtsson NE, Allen JM, Hauschka SD, Chamberlain JS. Development of novel micro-dystrophins with enhanced functionality. Mol Ther. 2019;27:623\u201335.","journal-title":"Mol Ther"},{"key":"8725_CR21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fphys.2020.00690","volume":"11","author":"TM Moore","year":"2020","unstructured":"Moore TM, Lin AJ, Strumwasser AR, Cory K, Whitney K, Ho T, et al. Mitochondrial dysfunction is an early consequence of partial or complete dystrophin loss in mdx mice. Front Physiol. 2020;11:690.","journal-title":"Front Physiol"},{"key":"8725_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-017-0139-5","volume":"7","author":"TL Kennedy","year":"2017","unstructured":"Kennedy TL, Moir L, Hemming S, Edwards B, Squire S, Davies K, et al. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle. Skelet Muscle. 2017;7:22.","journal-title":"Skelet Muscle"},{"key":"8725_CR23","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1093\/hmg\/ddr433","volume":"20","author":"LM Judge","year":"2011","unstructured":"Judge LM, Arnett AL, Banks GB, Chamberlain JS. Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice. Hum Mol Genet. 2011;20:4978\u201390.","journal-title":"Hum Mol Genet"},{"key":"8725_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/mus.20616","volume":"34","author":"DR Plant","year":"2006","unstructured":"Plant DR, Colarossi FE, Lynch GS. Notexin causes greater myotoxic damage and slower functional repair in mouse skeletal muscles than bupivacaine. Muscle Nerve. 2006;34:577\u201385.","journal-title":"Muscle Nerve"},{"key":"8725_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/BF02634119","volume":"31","author":"JD Rosenblatt","year":"1995","unstructured":"Rosenblatt JD, Lunt AI, Parry DJ, Partridge TA. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim. 1995;31:773\u201379.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"8725_CR26","first-page":"281","volume":"290","author":"G Shefer","year":"2005","unstructured":"Shefer G, Yablonka-Reuveni Z. Isolation and culture of skeletal muscle myofibres as a means to analyze satellite cells. Methods Mol Biol. 2005;290:281\u2013304.","journal-title":"Methods Mol Biol"},{"key":"8725_CR27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1083\/jcb.200711058","volume":"181","author":"P Konieczny","year":"2008","unstructured":"Konieczny P, Fuchs P, Reipert S, Kunz WS, Zeold A, Fischer I, et al. Myofibre integrity depends on desmin network targeting to Z-disks and costameres via distinct plectin isoforms. J Cell Biol. 2008;181:667\u201381.","journal-title":"J Cell Biol"},{"key":"8725_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"8725_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166\u201369.","journal-title":"Bioinformatics"},{"key":"8725_CR30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bioinformatics\/btu031","volume":"30","author":"P Jones","year":"2014","unstructured":"Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, et al. InterProScan 5: genome-scale protein function classification. Bioinformatics. 2014;30:1236\u201340.","journal-title":"Bioinformatics"},{"key":"8725_CR31","doi-asserted-by":"publisher","first-page":"W20","DOI":"10.1093\/nar\/gkh435","volume":"32","author":"S McGinnis","year":"2004","unstructured":"McGinnis S, Madden TL. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res. 2004;32:W20\u201325.","journal-title":"Nucleic Acids Res"},{"key":"8725_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"8725_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"8725_CR34","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.","journal-title":"Innovation"},{"key":"8725_CR35","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C. Pathview: an R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29:1830\u201331.","journal-title":"Bioinformatics"},{"key":"8725_CR36","doi-asserted-by":"publisher","unstructured":"Alexa A, Rahnenf\u00fchrer J. topGO: enrichment analysis for gene ontology. 2025. https:\/\/doi.org\/10.18129\/B9.bioc.topGO.","DOI":"10.18129\/B9.bioc.topGO"},{"key":"8725_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","volume":"90","author":"AE Deconinck","year":"1997","unstructured":"Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 1997;90:717\u201327.","journal-title":"Cell"},{"key":"8725_CR38","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/ijms12031660","volume":"12","author":"M Nakamori","year":"2011","unstructured":"Nakamori M, Takahashi MP. The role of alpha-dystrobrevin in striated muscle. Int J Mol Sci. 2011;12:1660\u201371.","journal-title":"Int J Mol Sci"},{"key":"8725_CR39","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.nmd.2017.06.007","volume":"27","author":"M Matsumoto","year":"2017","unstructured":"Matsumoto M, Awano H, Lee T, Takeshima Y, Matsuo M, Iijima K. Patients with Duchenne muscular dystrophy are significantly shorter than those with Becker muscular dystrophy, with the higher incidence of short stature in Dp71 mutated subgroup. Neuromuscul Disord. 2017;27:1023\u201328.","journal-title":"Neuromuscul Disord"},{"key":"8725_CR40","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/jcsm.12914","volume":"13","author":"M Chesshyre","year":"2022","unstructured":"Chesshyre M, Ridout D, Hashimoto Y, Ookubo Y, Torelli S, Maresh K, et al. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy. J Cachexia Sarcopenia Muscle. 2022;13:1360\u201372.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"8725_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ajpath.2019.09.021","volume":"190","author":"CNJ Young","year":"2020","unstructured":"Young CNJ, Gosselin MRF, Rumney R, Oksiejuk A, Chira N, Bozycki L, et al. Total absence of dystrophin expression exacerbates ectopic myofibre calcification and fibrosis and alters macrophage infiltration patterns. Am J Pathol. 2020;190:190\u2013205.","journal-title":"Am J Pathol"},{"key":"8725_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1006\/geno.1997.4905","volume":"45","author":"HG Lidov","year":"1997","unstructured":"Lidov HG, Kunkel LM. Dp140: alternatively spliced isoforms in brain and kidney. Genomics. 1997;45:132\u20139.","journal-title":"Genomics"},{"key":"8725_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/hmg\/ddac236","volume":"32","author":"C Garcia-Cruz","year":"2023","unstructured":"Garcia-Cruz C, Aragon J, Lourdel S, Annan A, Roger JE, Montanez C, et al. Tissue- and cell-specific whole-transcriptome meta-analysis from brain and retina reveals differential expression of dystrophin complexes and new dystrophin spliced isoforms. Hum Mol Genet. 2023;32:659\u201376.","journal-title":"Hum Mol Genet"},{"key":"8725_CR44","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1073\/pnas.89.12.5346","volume":"89","author":"D Lederfein","year":"1992","unstructured":"Lederfein D, Levy Z, Augier N, Mornet D, Morris G, Fuchs O, et al. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci USA. 1992;89:5346\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8725_CR45","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1242\/jcs.02908","volume":"119","author":"PS Zammit","year":"2006","unstructured":"Zammit PS, Relaix F, Nagata Y, Ruiz AP, Collins CA, Partridge TA, et al. Pax7 and myogenic progression in skeletal muscle satellite cells. J Cell Sci. 2006;119:1824\u201332.","journal-title":"J Cell Sci"},{"key":"8725_CR46","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/mus.23738","volume":"47","author":"P Konieczny","year":"2013","unstructured":"Konieczny P, Swiderski K, Chamberlain JS. Gene and cell-mediated therapies for muscular dystrophy. Muscle Nerve. 2013;47:649\u201363.","journal-title":"Muscle Nerve"},{"key":"8725_CR47","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00441-010-0976-6","volume":"340","author":"M Kottlors","year":"2010","unstructured":"Kottlors M, Kirschner J. Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res. 2010;340:541\u201348.","journal-title":"Cell Tissue Res"},{"key":"8725_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1180980","volume":"14","author":"K Kodippili","year":"2023","unstructured":"Kodippili K, Rudnicki MA. Satellite cell contribution to disease pathology in Duchenne muscular dystrophy. Front Physiol. 2023;14:1180980.","journal-title":"Front Physiol"},{"key":"8725_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.scr.2018.05.004","volume":"30","author":"J Meng","year":"2018","unstructured":"Meng J, Muntoni F, Morgan J. CD133+ cells derived from skeletal muscles of Duchenne muscular dystrophy patients have a compromised myogenic and muscle regenerative capability. Stem Cell Res. 2018;30:43\u201352.","journal-title":"Stem Cell Res"},{"key":"8725_CR50","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1073\/pnas.80.15.4856","volume":"80","author":"HM Blau","year":"1983","unstructured":"Blau HM, Webster C, Pavlath GK. Defective myoblasts identified in Duchenne muscular dystrophy. Proc Natl Acad Sci USA. 1983;80:4856\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8725_CR51","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med. 2015;21:1455\u201363.","journal-title":"Nat Med"},{"key":"8725_CR52","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"A Sacco","year":"2010","unstructured":"Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P, et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice. Cell. 2010;143:1059\u201371.","journal-title":"Cell"},{"key":"8725_CR53","doi-asserted-by":"crossref","unstructured":"Jimenez-Gutierrez GE, Mondragon-Gonzalez R, Soto-Ponce LA, Gomez-Monsivais WL, Garcia-Aguirre I, Pacheco-Rivera RA, et al. Loss of dystroglycan drives cellular senescence via defective mitosis-mediated genomic instability. Int J Mol Sci. 2020;21:4961.","DOI":"10.3390\/ijms21144961"},{"key":"8725_CR54","doi-asserted-by":"crossref","unstructured":"Cook M, Stevenson B, Jacobs LA, Leocadio Victoria D, Cisneros B, Hobbs JK, et al. The role of beta-dystroglycan in nuclear dynamics. Cells 2024;13:431.","DOI":"10.3390\/cells13050431"},{"key":"8725_CR55","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0092-8674(02)00907-8","volume":"110","author":"RD Cohn","year":"2002","unstructured":"Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, et al. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 2002;110:639\u201348.","journal-title":"Cell"},{"key":"8725_CR56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/15519","volume":"23","author":"PD Cote","year":"1999","unstructured":"Cote PD, Moukhles H, Lindenbaum M, Carbonetto S. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet. 1999;23:338\u201342.","journal-title":"Nat Genet"},{"key":"8725_CR57","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s12035-019-01845-w","volume":"57","author":"M Naidoo","year":"2020","unstructured":"Naidoo M, Anthony K. Dystrophin Dp71 and the neuropathophysiology of duchenne muscular dystrophy. Mol Neurobiol. 2020;57:1748\u201367.","journal-title":"Mol Neurobiol"},{"key":"8725_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0014-5793(93)80992-4","volume":"328","author":"D Rapaport","year":"1993","unstructured":"Rapaport D, Greenberg DS, Tal M, Yaffe D, Nudel U. Dp71, the nonmuscle product of the Duchenne muscular dystrophy gene is associated with the cell membrane. FEBS Lett. 1993;328:197\u2013202.","journal-title":"FEBS Lett"},{"key":"8725_CR59","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1242\/jcs.02857","volume":"119","author":"LM Judge","year":"2006","unstructured":"Judge LM, Haraguchiln M, Chamberlain JS. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex. J Cell Sci. 2006;119:1537\u201346.","journal-title":"J Cell Sci"},{"key":"8725_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nmd.2024.01.004","volume":"36","author":"S Krishna","year":"2024","unstructured":"Krishna S, Piepho AB, Lake DM, Cumby LR, Lortz KK, Lowe J, et al. Gene therapy delivered micro-dystrophins co-localize with transgenic utrophin in dystrophic skeletal muscle fibers. Neuromuscul Disord. 2024;36:1\u20135.","journal-title":"Neuromuscul Disord"},{"key":"8725_CR61","doi-asserted-by":"crossref","unstructured":"Aartsma-Rus A, van Putten M. Assessing functional performance in the mdx mouse model. J Vis Exp. 2014;85:e51303.","DOI":"10.3791\/51303-v"},{"key":"8725_CR62","doi-asserted-by":"publisher","first-page":"12140","DOI":"10.1021\/acsnano.8b05721","volume":"12","author":"S Le","year":"2018","unstructured":"Le S, Yu M, Hovan L, Zhao Z, Ervasti J, Yan J. Dystrophin as a molecular shock absorber. ACS Nano. 2018;12:12140\u201348.","journal-title":"ACS Nano"},{"key":"8725_CR63","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00007.2015","volume":"96","author":"DG Allen","year":"2016","unstructured":"Allen DG, Whitehead NP, Froehner SC. Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol Rev. 2016;96:253\u2013305.","journal-title":"Physiol Rev"},{"key":"8725_CR64","doi-asserted-by":"publisher","first-page":"ra56","DOI":"10.1126\/scisignal.2002829","volume":"5","author":"RJ Khairallah","year":"2012","unstructured":"Khairallah RJ, Shi G, Sbrana F, Prosser BL, Borroto C, Mazaitis MJ, et al. Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal. 2012;5:ra56.","journal-title":"Sci Signal"},{"key":"8725_CR65","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1113\/jphysiol.2014.274878","volume":"592","author":"JG Tidball","year":"2014","unstructured":"Tidball JG, Wehling-Henricks M. Nitric oxide synthase deficiency and the pathophysiology of muscular dystrophy. J Physiol. 2014;592:4627\u201338.","journal-title":"J Physiol"},{"key":"8725_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06057-9","volume":"9","author":"JE Morgan","year":"2018","unstructured":"Morgan JE, Prola A, Mariot V, Pini V, Meng J, Hourde C, et al. Necroptosis mediates myofibre death in dystrophin-deficient mice. Nat Commun. 2018;9:3655.","journal-title":"Nat Commun"},{"key":"8725_CR67","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/j.2040-4603.2018.tb00051.x","volume":"8","author":"JG Tidball","year":"2018","unstructured":"Tidball JG, Welc SS, Wehling-Henricks M. Immunobiology of inherited muscular dystrophies. Compr Physiol. 2018;8:1313\u201356.","journal-title":"Compr Physiol"},{"key":"8725_CR68","volume":"2011","author":"JD Gumerson","year":"2011","unstructured":"Gumerson JD, Michele DE. The dystrophin-glycoprotein complex in the prevention of muscle damage. J Biomed Biotechnol. 2011;2011:210797.","journal-title":"J Biomed Biotechnol"},{"key":"8725_CR69","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1073\/pnas.1323842111","volume":"111","author":"JJ Belanto","year":"2014","unstructured":"Belanto JJ, Mader TL, Eckhoff MD, Strandjord DM, Banks GB, Gardner MK, et al. Microtubule binding distinguishes dystrophin from utrophin. Proc Natl Acad Sci USA. 2014;111:5723\u201328.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8725_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12014-015-9099-0","volume":"12","author":"S Murphy","year":"2015","unstructured":"Murphy S, Zweyer M, Henry M, Meleady P, Mundegar RR, Swandulla D, et al. Label-free mass spectrometric analysis reveals complex changes in the brain proteome from the mdx-4cv mouse model of Duchenne muscular dystrophy. Clin Proteomics. 2015;12:27.","journal-title":"Clin Proteomics"},{"key":"8725_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30545-8","volume":"13","author":"A Riba","year":"2022","unstructured":"Riba A, Oravecz A, Durik M, Jimenez S, Alunni V, Cerciat M, et al. Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning. Nat Commun. 2022;13:2865.","journal-title":"Nat Commun"},{"key":"8725_CR72","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s42003-023-04666-9","volume":"6","author":"HJ Gleneadie","year":"2023","unstructured":"Gleneadie HJ, Fernandez-Ruiz B, Sardini A, Van de Pette M, Dimond A, Prinjha RK, et al. Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1\/2 inhibition. Commun Biol. 2023;6:318.","journal-title":"Commun Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08725-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08725-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08725-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:02:03Z","timestamp":1779080523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08725-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8725"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08725-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JSC is one of the inventors on patents covering muscle-specific gene editing and patents covering muscle-specific gene regulatory cassettes, micro-dystrophins, and systemic delivery of AAV. JSC holds equity in and is a member of the scientific advisory board of Solid Biosciences. All the other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}